Giving common muscle relaxant via nose shows potential to treat neurodegenerative diseases

by Perelman School of Medicine at the University of PennsylvaniaPET scan of a human brain with Alzheimer's disease. Credit: public domainDelivering the medication dantrolene through the nose

Updated on: July 01,2024 6

Giving common muscle relaxant via nose shows potential to treat neurodegenerative diseases

by Perelman School of Medicine at the University of PennsylvaniaPET scan of a human brain with Alzheimer's disease. Credit: public domainDelivering the medication dantrolene through the nose

Updated on:July 01,2024 6

Combination of healthy lifestyle traits may substantially reduce Alzheimer's disease risk

by National Institutes of HealthCombining four or five healthy lifestyle behaviors -- such as swimming -- may lower risk of Alzheimer's disease. Credit: NIH/National Institute on AgingCombini

Updated on: July 01,2024 5

Combination of healthy lifestyle traits may substantially reduce Alzheimer's disease risk

by National Institutes of HealthCombining four or five healthy lifestyle behaviors -- such as swimming -- may lower risk of Alzheimer's disease. Credit: NIH/National Institute on AgingCombini

Updated on:July 01,2024 5

Poor metabolic health could increase risk of developing dementia later in life

by University of OxfordCredit: CC0 Public DomainResearchers at Oxford Population Health have found that having poor metabolic health was related to an increased risk of developing dementia in a s

Updated on: March 02,2024 19

Poor metabolic health could increase risk of developing dementia later in life

by University of OxfordCredit: CC0 Public DomainResearchers at Oxford Population Health have found that having poor metabolic health was related to an increased risk of developing dementia in a s

Updated on:March 02,2024 19

Vascular risk factors and Alzheimer's disease—a new therapeutic opportunity?

by IOS PressCurrently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment. Metaboli

Updated on: March 07,2024 13

Vascular risk factors and Alzheimer's disease—a new therapeutic opportunity?

by IOS PressCurrently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment. Metaboli

Updated on:March 07,2024 13

Can online therapy reduce distress in dementia carers?

by University of ExeterCaring is both rewarding and demanding. Credit: University of ExeterA new study is inviting people who care for someone with dementia to help investigate whether an online

Updated on: March 09,2024 12

Can online therapy reduce distress in dementia carers?

by University of ExeterCaring is both rewarding and demanding. Credit: University of ExeterA new study is inviting people who care for someone with dementia to help investigate whether an online

Updated on:March 09,2024 12

Genes, cardiovascular health each factor into dementia risk

by University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainGenes and cardiovascular health each contribute in an additive way to a person's risk of dementia, U.S. res

Updated on: June 14,2024 4

Genes, cardiovascular health each factor into dementia risk

by University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainGenes and cardiovascular health each contribute in an additive way to a person's risk of dementia, U.S. res

Updated on:June 14,2024 4

Bag of words test for Alzheimer's disease

by David Bradley,InderscienceCredit: CC0 Public DomainA positive diagnosis of Alzheimer's disease (AD) can only be made definitively postmortem. However, there are many symptoms that become

Updated on: April 18,2024 14

Bag of words test for Alzheimer's disease

by David Bradley,InderscienceCredit: CC0 Public DomainA positive diagnosis of Alzheimer's disease (AD) can only be made definitively postmortem. However, there are many symptoms that become

Updated on:April 18,2024 14

Human brains are getting larger: That may be good news for dementia risk

byUC DavisHuman brain volume has increased for people born in the 1970s compared to the 1930s. Credit: UC Davis HealthA new study by researchers at UC Davis Health found human brains are getting

Updated on: March 28,2024 0

Human brains are getting larger: That may be good news for dementia risk

byUC DavisHuman brain volume has increased for people born in the 1970s compared to the 1930s. Credit: UC Davis HealthA new study by researchers at UC Davis Health found human brains are getting

Updated on:March 28,2024 0

People with dementia and the right to independent life

by Risto Löf,University of Eastern FinlandTuija Alava, an expert by experience for Pohjois-Savon Muisti, was diagnosed with Alzheimer’s disease while still in working life. Alava lives alone and

Updated on: May 08,2024 5

People with dementia and the right to independent life

by Risto Löf,University of Eastern FinlandTuija Alava, an expert by experience for Pohjois-Savon Muisti, was diagnosed with Alzheimer’s disease while still in working life. Alava lives alone and

Updated on:May 08,2024 5

New imaging technique in Alzheimer's disease opens up possibilities for drug development

by Lund UniversityThe brain of an Alzheimer’s patient in a tau PET image. Red indicates the areas with the highest concentration of the tau protein. In the magnifying glass, a microscope enlargem

Updated on: April 07,2024 19

New imaging technique in Alzheimer's disease opens up possibilities for drug development

by Lund UniversityThe brain of an Alzheimer’s patient in a tau PET image. Red indicates the areas with the highest concentration of the tau protein. In the magnifying glass, a microscope enlargem

Updated on:April 07,2024 19

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on: November 11,2024 0

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on:November 11,2024 0

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company

Updated on: March 30,2024 13

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company

Updated on:March 30,2024 13